Oxycodone/naloxone prolonged release tablets – innovation in the treatment of pain. Case report

Feliks Błaszczyk; Aleksandra Droń

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

3/2012
vol. 4

Send email

Copy url:

abstract:

Case report

Oxycodone/naloxone prolonged release tablets – innovation in the treatment of pain. Case report

Feliks Błaszczyk

,

Aleksandra Droń

Medycyna Paliatywna 2012; 3: 181–184

Online publish date: 2012/11/28

View full text Get citation

Pain afflicts patients suffering from chronic diseases, and accompanies 80% of patients with advanced cancer suffer from persistent pain. The aim of the pain treatment is to achieve maximum analgetic effect at the minimum side effects rate. The main antianalgesic in the past was morphine, however this therapy brings about gastrointestinal side effects. The alternative to that seems the combination of oxycodone and naloxone in the available medication Targin^® (Mundipharma). In this article we present the case of 68 year-old patient, who was treated effectively with oxycodone/naloxone prolonged release tablets. This treatment succeded in efficient pain and constipation control agent.

keywords:

Oxycodone/naloxone prolonged release tablets – innovation in the treatment of pain. Case report

Feliks Błaszczyk , Aleksandra Droń

pain, constipation, opioids, oxycodone/naloxone

Feliks Błaszczyk

,

Aleksandra Droń